Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer

Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal Cancer

Integrating immunotherapy, proton therapy and biological dose escalation into the definitive chemoradiation of oropharyngeal cancer poses several challenges. Reliable and reproducible data must be obtained in a timely fashion. However, despite recent international radiotherapy contouring guidelines,...

Full description

Bibliographic Details
Main Authors:	Agostino Cristaudo, Mitchell Hickman, Charles Fong, Paul Sanghera, Andrew Hartley
Format:	Article
Language:	English
Published:	MDPI AG 2018-06-01
Series:	Medicines
Subjects:	clinical target volume (CTV) mucositis organ at risk (OAR) intensity modulated proton therapy (IMPT) PET/CT
Online Access:	http://www.mdpi.com/2305-6320/5/3/65

Similar Items

Intensity-Modulated Proton Therapy (IMPT) Treatment of Angiosarcoma of the Face and Scalp
by: Ashley Hunzeker, MS, CMD, et al.
Published: (2021-06-01)

The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers
by: Jaden D. Evans, MD, et al.
Published: (2020-08-01)

Influence of 68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy
by: Falk Stade, et al.
Published: (2018-04-01)

Pro-con of proton: Dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies
by: Ang Wei Jie, et al.
Published: (2020-09-01)

The Role of MRSI in Target Volume Definition for Radiation Therapy of Prostate Cancer
by: Mostafa Robatjazi, et al.
Published: (2011-09-01)

Influence of Target Location, Size, and Patient Age on Normal Tissue Sparing- Proton and Photon Therapy in Paediatric Brain Tumour Patient-Specific Approach
by: Mikaela Dell’Oro, et al.
Published: (2020-09-01)

Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer
by: Nikhil G. Thaker, MD, et al.
Published: (2021-06-01)

Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy
by: Alexander Chi, et al.
Published: (2017-08-01)

An Interpretation of International Guideline for Delineation of Clinical Target Volumes for Nasopharyngeal Carcinoma in 2017
by: YU Lushi, et al.
Published: (2019-01-01)

Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy
by: Zahra Siavashpour, et al.
Published: (2016-04-01)

Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China
by: Shichuan Zhang, et al.
Published: (2020-08-01)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
by: Saba Ebrahimi, BSc, et al.
Published: (2021-04-01)

Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment
by: Kekoa Taparra, MD, PhD, et al.
Published: (2020-09-01)

Investigating dosimetric effect of rotational setup errors in IMPT planning of synchronous bilateral lung cancer
by: Suresh Rana, et al.
Published: (2015-12-01)

First report on extended distance between tumor lesion and adjacent organs at risk using interventionally applied balloon catheters: a simple procedure to optimize clinical target volume covering effective isodose in interstitial high-dose-rate brachytherapy of liver malignomas
by: Peter Hass, et al.
Published: (2019-04-01)

A prospective comparison of common toxicity criteria adverse events Version 3 and 4 in assessing oral mucositis for oral and oropharyngeal carcinoma
by: M. Hickman, et al.
Published: (2017-03-01)

4D FDG-PET based treatment planning for IGRT in the treatment of lung cancer
by: Alexander eChi, et al.
Published: (2014-08-01)

Towards Effective and Efficient Patient-Specific Quality Assurance for Spot Scanning Proton Therapy
by: X. Ronald. Zhu, et al.
Published: (2015-04-01)

Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy
by: Peilin Liu, et al.
Published: (2021-09-01)

Molecular and biological evidence for a severe seedling yellows strain of <em>Citrus tristeza virus</em> spreading in southern Italy
by: Luca FERRETTI, et al.
Published: (2014-04-01)

Journal of Proton Therapy
by: Editorial Office
Published: (2015-01-01)

The role of breath hold intensity modulated proton therapy for a case of left-sided breast cancer with IMN involvement. How protons compare with other conformal techniques?
by: H.L. Lee, et al.
Published: (2020-09-01)

Significant Reduction in Vertebral Artery Dose by Intensity Modulated Proton Therapy: A Pilot Study for Nasopharyngeal Carcinoma
by: Yun-Hsuan Lin, et al.
Published: (2021-08-01)

Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness
by: Guo Li, et al.
Published: (2021-08-01)

Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study
by: Yung-Chih Chou, et al.
Published: (2021-07-01)

Automated clinical target volume delineation using deep 3D neural networks in radiation therapy of Non-small Cell Lung Cancer
by: Yunhe Xie, et al.
Published: (2021-07-01)

Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases
by: Gracinda Mondlane, et al.
Published: (2018-10-01)

Clinical application of intensity and energy modulated radiotherapy with photon and electron beams
by: Mu, Xiangkui
Published: (2005)

The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma
by: Maciej J. Pelak, et al.
Published: (2021-09-01)

Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines
by: Hendrik Dapper, et al.
Published: (2019-07-01)

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
by: Sebastian Adeberg, et al.
Published: (2018-10-01)

Automated Knowledge-Based Intensity-Modulated Proton Planning: An International Multicenter Benchmarking Study
by: Alexander R. Delaney, et al.
Published: (2018-11-01)

Arms positioning in post-mastectomy proton radiation: Feasibility and development of a new arms down contouring atlas
by: Nicolas Depauw, et al.
Published: (2020-04-01)

Impact of <sup>18</sup>F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
by: Vees Hansjörg, et al.
Published: (2012-10-01)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
by: Katie eNewbold, et al.
Published: (2012-12-01)

Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy
by: Zhang, Pengfei, et al.
Published: (2017)

Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study
by: Fang Liu, et al.
Published: (2019-06-01)

Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy
by: Yihang Xu, BS, et al.
Published: (2021-06-01)

CBCT-Based Adaptive Assessment Workflow for Intensity Modulated Proton Therapy for Head and Neck Cancer
by: De Ornelas Mariluz, PhD, et al.
Published: (2021-03-01)

The genetics of tolerance to tristeza disease in citrus rootstocks
by: Rita Bordignon, et al.
Published: (2004-01-01)

Cannot write session to /tmp/vufind_sessions/sess_bsbq4do8p3bqeg38d4t6jdcab0